Immobilase began with an accident in the lab. During her PhD at University College London, Amy was exploring 3D printing for enzyme-controlled drug delivery when she stumbled on something unexpected.
After loading enzymes onto a 3D-printed scaffold, she left the construct out at room temperature for a month, assuming the enzymes would be inactive. On a whim, she tested it anyway. To her surprise, it still worked.
Today, we’ve successfully immobilised a range of enzymes and kept them active for over eight months (and counting).
What started as a seredipitous moment is now a focused mission: to deliver fast, reliable, and customisable immobilised enzyme products that are tailored for real-world use.